← All companies
XBIO
Xenetic Biosciences, Inc.
$2.66
+0.11 +4.31%
Key statistics
from XBRL data in SEC filingsMarket cap
$6.09M
Revenue (TTM)
$3.19M
Net income (TTM)
-$2.23M
EPS (TTM)
$-1.19
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$7.35M
Total assets
$7.91M
Gross margin
—
52-week range
$1.90 – $13.93
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Results of operations (earnings release)
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 12, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 24, 2026
8-K
Director or officer change
Apr 24, 2026
8-K
Results of operations (earnings release)
Mar 13, 2026
10-K
Fiscal year ended 2025-12-31
Mar 12, 2026
8-K
Other events
Jan 9, 2026
8-K
Regulation FD disclosure
Dec 11, 2025
8-K
Results of operations (earnings release)
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 12, 2025
8-K
Entered a material agreement; Other events
Oct 14, 2025
8-K
Results of operations (earnings release)
Aug 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Results of operations (earnings release)
May 14, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
10-K/A
Fiscal year ended 2024-12-31
May 13, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 29, 2025
8-K
Changed accountants
Apr 10, 2025
8-K/A
AMENDMENT NO 1
Mar 19, 2025
8-K
Results of operations (earnings release)
Mar 19, 2025
10-K
Fiscal year ended 2024-12-31
Mar 18, 2025
8-K
Shareholder vote results
Dec 13, 2024
8-K
Results of operations (earnings release)
Nov 13, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Entered a material agreement; Regulation FD disclosure
Nov 7, 2024
8-K
Director or officer change
Oct 31, 2024
8-K
Results of operations (earnings release)
Aug 14, 2024
10-Q
Quarter ended 2024-06-30
Aug 13, 2024
8-K
Director or officer change
Jun 21, 2024
8-K
Director or officer change; Regulation FD disclosure
May 22, 2024
8-K
Results of operations (earnings release)
May 10, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
10-K/A
Fiscal year ended 2023-12-31
Apr 26, 2024
8-K
Results of operations (earnings release)
Mar 22, 2024
10-K
Fiscal year ended 2023-12-31
Mar 21, 2024
8-K
Regulation FD disclosure
Feb 12, 2024
8-K
Shareholder vote results
Dec 8, 2023
8-K
Results of operations (earnings release)
Nov 13, 2023
10-Q
Quarter ended 2023-09-30
Nov 9, 2023
8-K
Results of operations (earnings release)
Aug 11, 2023